Twelve months of nightly zolpidem does not lead to dose escalation: A prospective placebo-controlled study

Sleep

Volumn 34, Issue 2, 2011, Pages 207-212

  Roehrs, Timothy A ^a,b   Randall, Surilla ^a   Harris, Erica ^a   Maan, Renee ^a   Roth, Thomas ^a,b  

^a HENRY FORD HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic nightly use; Primary insomnia; Self administration; Zolpidem

Indexed keywords

ZOLPIDEM;

ADULT; ALCOHOL ABUSE; ARTICLE; BEDTIME DOSAGE; CLINICAL ARTICLE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG CAPSULE; DRUG DOSE ESCALATION; DRUG SELF ADMINISTRATION; FEMALE; HUMAN; INSOMNIA; LABORATORY TEST; MALE; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SAMPLING; SLEEP;

EID: 79851483617     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/34.2.207     Document Type: Article

References (15)

1. Woods JH, Winger G. Current benzodiazepine issues. Psychopharmacology 1995;118:107-15.
2. Fach M, Bischof G, Schmidt C, Rumpf HJ. Prevalence of dependence on prescription drugs and associated mental disorders in a representative sample of general hospital patients. Gen Hosp Psychiatry 2007;29:257-63. (Pubitemid 46678218)
3. Victorri-Vigneau C, Dailly E, Veyrac G, Joillet P. Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 2007;64:198-209. (Pubitemid 47063241)
4. Kan CC, Hilbedrink SR, Breteier MHM. Determination of the main risk factors for benzodiazepine dependence using a multivariate and multidimensional approach. Comp Psychiatry 2004;45:88-94. (Pubitemid 38332704)
5. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Arch Gen Psychiatry 1985;42:225-32.
6. Roehrs T, Hollebeek E, Drake C, et al. Substance use for insomnia in Metropolitan Detroit. J Psychosom Res 2002;53:571-6.
7. Krystal AD, Walsh JK, Laska E, et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: Results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003;26:793-9. (Pubitemid 39610622)
8. Walsh J, Krystal A, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: Effect on sleep, quality of life, and work limitations. Sleep 2007;30:959-68. (Pubitemid 47221895)
9. Roehrs T, Bonahoom A, Pedrosi B, Rosenthal L, Roth T. Disturbed sleep predicts hypnotic self administration. Sleep Med 2002;3:61-6. (Pubitemid 34177188)
10. Roehrs T, Pedrosi B, Rosenthal L,Roth T. Hypnotic self administration and dose escalation. Psychopharmacology 1996;127:150-4. (Pubitemid 26298013)
11. Roehrs T, Merlotti L, Zorick F, Roth T. Rebound insomnia and hypnotic self administration. Psychopharmacology 1992;107:480-4.
12. Roehrs T, Bonahoom A, Pedrosi B, Roth T. Nighttime versus daytime hypnotic self-administration. Psychopharmacology 2002;161:137-42. (Pubitemid 34492658)
13. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Washington D.C. Public Health Service, U.S. Government Printing Office, 1968.
14. Coleman RM. Periodic movements I sleep (nocturnal myoclonus) and restless legs syndrome. In: Guilleminault, C. (ed.), Sleeping and waking disorders: indications and techniques, pp. 265-295. Menlo Park, CA: Addison-Wesley Publishing Co, 1982.
15. Bornstein SK. Respiratory monitoring during sleep: polysomnography. In: Guilleminault, C. (ed.), Sleeping and waking disorders: indications and techniques, pp. 183-212. Menlo Park, CA: Addison-Wesley Publishing Co, 1982.